6 New Studies on Emerging GI Disease Interventions and Concerns | Medscape

David Johnson, MD, continues his deep dive into the most compelling data from the American College of Gastroenterology (ACG) Annual Meeting. This video focuses on critical new findings related to pancreatic cancer detection, the gastrointestinal effects of immune checkpoint inhibitors, and novel therapeutic approaches. This second part of the ACG highlights summarizes high-impact clinical research in gastroenterology, featuring a novel serum-based test for pancreatic ductal adenocarcinoma with promising early-stage accuracy. The discussion shifts to the GI effects of immunotherapy, detailing the risk of adenoma development following immune checkpoint inhibitor colitis, emphasizing the need for timely colonoscopy screening. We also cover new strategies for managing checkpoint inhibitor-mediated colitis to reduce readmission risk. Furthermore, we explore exciting investigative treatments, including pancreatic cooling for acute pancreatitis and the use of an allogeneic cell therapy injection for Crohn’s perianal fistulas. Finally, the video concludes with an alert on emerging research regarding the potential GI effects of microplastics on gut health. 00:00 - Introduction to ACG Highlights 00:27 - Serum Test for Pancreatic Ductal Adenocarcinoma 01:49 - Adenoma Risk After Immune Checkpoint Inhibitor Colitis 02:59 - Managing Immune Checkpoint Inhibitor Colitis & Readmission Risk 04:30 - Investigational Pancreatic Cooling for Acute Pancreatitis 06:05 - Cell Therapy Injection for Crohn’s Perianal Fistulas 07:38 - Microplastics: GI Effects and Future Research 09:47 - Conclusion #Gastroenterology #ACG2025 #PancreaticCancer #CrohnsDisease #CheckpointInhibitors #Microplastics #AcutePancreatitis #ClinicalTrials #MedicalResearch #GIHacks